Asset Management
Compare Stocks
4 / 10Stock Comparison
INV vs HON vs MMM vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Conglomerates
Conglomerates
Industrial - Machinery
INV vs HON vs MMM vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Asset Management | Conglomerates | Conglomerates | Industrial - Machinery |
| Market Cap | $349M | $136.91B | $74.98B | $79.02B |
| Revenue (TTM) | $1M | $36.76B | $25.02B | $18.32B |
| Net Income (TTM) | $-317M | $4.10B | $2.79B | $2.44B |
| Gross Margin | -271.2% | 36.9% | 39.5% | 52.7% |
| Operating Margin | -63.2% | 14.9% | 19.6% | 19.8% |
| Forward P/E | — | 20.5x | 16.6x | 21.7x |
| Total Debt | $28M | $34.58B | $12.94B | $13.76B |
| Cash & Equiv. | $11M | $12.49B | $5.24B | $1.54B |
INV vs HON vs MMM vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 21 | May 26 | Return |
|---|---|---|---|
| Innventure, Inc. (INV) | 100 | 70.0 | -30.0% |
| Honeywell Internati… (HON) | 100 | 105.4 | +5.4% |
| 3M Company (MMM) | 100 | 100.8 | +0.8% |
| Emerson Electric Co. (EMR) | 100 | 160.8 | +60.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: INV vs HON vs MMM vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
INV has the current edge in this matchup, primarily because of its strength in growth and momentum.
- 9.2% NII/revenue growth vs MMM's 1.5%
- +59.2% vs HON's +2.8%
HON is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Lower volatility, beta 0.74, current ratio 1.32x
- Beta 0.74, yield 2.1%, current ratio 1.32x
- Beta 0.74 vs INV's 2.63
MMM is the clearest fit if your priority is value and efficiency.
- Better valuation composite
- 7.5% ROA vs INV's -47.4%, ROIC 28.1% vs -14.8%
EMR is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 3.0%, EPS growth 17.8%, 3Y rev CAGR 9.3%
- 206.6% 10Y total return vs HON's 135.1%
- PEG 4.81 vs HON's 11.18
- 13.3% margin vs INV's -64.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.2% NII/revenue growth vs MMM's 1.5% | |
| Value | Better valuation composite | |
| Quality / Margins | 13.3% margin vs INV's -64.1% | |
| Stability / Safety | Beta 0.74 vs INV's 2.63 | |
| Dividends | 2.1% yield, 15-year raise streak, vs EMR's 1.5% | |
| Momentum (1Y) | +59.2% vs HON's +2.8% | |
| Efficiency (ROA) | 7.5% ROA vs INV's -47.4%, ROIC 28.1% vs -14.8% |
INV vs HON vs MMM vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
INV vs HON vs MMM vs EMR — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MMM leads in 2 of 6 categories
EMR leads 1 • HON leads 1 • INV leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EMR leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 30133.6x INV's $1M. EMR is the more profitable business, keeping 13.3% of every revenue dollar as net income compared to INV's -64.1%. On growth, EMR holds the edge at +2.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1M | $36.8B | $25.0B | $18.3B |
| EBITDAEarnings before interest/tax | -$451M | $6.5B | $5.2B | $4.7B |
| Net IncomeAfter-tax profit | -$317M | $4.1B | $2.8B | $2.4B |
| Free Cash FlowCash after capex | -$87M | $4.2B | $2.1B | $3.1B |
| Gross MarginGross profit ÷ Revenue | -2.7% | +36.9% | +39.5% | +52.7% |
| Operating MarginEBIT ÷ Revenue | -63.2% | +14.9% | +19.6% | +19.8% |
| Net MarginNet income ÷ Revenue | -64.1% | +11.2% | +11.1% | +13.3% |
| FCF MarginFCF ÷ Revenue | -40.2% | +11.4% | +8.2% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -6.9% | +1.3% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -9.3% | -41.9% | -39.7% | +28.2% |
Valuation Metrics
MMM leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 24.0x trailing earnings, MMM trades at a 31% valuation discount to EMR's 34.9x P/E. Adjusting for growth (PEG ratio), EMR offers better value at 7.73x vs HON's 15.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $349M | $136.9B | $75.0B | $79.0B |
| Enterprise ValueMkt cap + debt − cash | $366M | $159.0B | $82.7B | $91.2B |
| Trailing P/EPrice ÷ TTM EPS | -3.55x | 29.36x | 23.96x | 34.92x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.52x | 16.55x | 21.71x |
| PEG RatioP/E ÷ EPS growth rate | — | 15.99x | — | 7.73x |
| EV / EBITDAEnterprise value multiple | — | 19.99x | 15.20x | 18.07x |
| Price / SalesMarket cap ÷ Revenue | 286.17x | 3.66x | 3.01x | 4.39x |
| Price / BookPrice ÷ Book value/share | 0.36x | 9.00x | 16.32x | 3.94x |
| Price / FCFMarket cap ÷ FCF | — | 25.39x | 53.71x | 29.63x |
Profitability & Efficiency
MMM leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MMM delivers a 65.3% return on equity — every $100 of shareholder capital generates $65 in annual profit, vs $-59 for INV. INV carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to MMM's 2.73x. On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs INV's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -58.9% | +23.1% | +65.3% | +12.1% |
| ROA (TTM)Return on assets | -47.4% | +5.3% | +7.5% | +5.8% |
| ROICReturn on invested capital | -14.8% | +12.6% | +28.1% | +8.2% |
| ROCEReturn on capital employed | -18.1% | +12.6% | +16.1% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.04x | 2.24x | 2.73x | 0.68x |
| Net DebtTotal debt minus cash | $17M | $22.1B | $7.7B | $12.2B |
| Cash & Equiv.Liquid assets | $11M | $12.5B | $5.2B | $1.5B |
| Total DebtShort + long-term debt | $28M | $34.6B | $12.9B | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | -57.53x | 3.92x | 6.52x | 6.46x |
Total Returns (Dividends Reinvested)
Evenly matched — INV and MMM and EMR each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EMR five years ago would be worth $15,945 today (with dividends reinvested), compared to $6,210 for INV. Over the past 12 months, INV leads with a +59.2% total return vs HON's +2.8%. The 3-year compound annual growth rate (CAGR) favors MMM at 21.8% vs INV's -15.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +38.6% | +10.9% | -10.7% | +4.3% |
| 1-Year ReturnPast 12 months | +59.2% | +2.8% | +5.8% | +30.4% |
| 3-Year ReturnCumulative with dividends | -40.0% | +16.2% | +80.7% | +75.9% |
| 5-Year ReturnCumulative with dividends | -37.9% | +3.3% | -3.1% | +59.5% |
| 10-Year ReturnCumulative with dividends | -37.9% | +135.1% | +32.5% | +206.6% |
| CAGR (3Y)Annualised 3-year return | -15.7% | +5.1% | +21.8% | +20.7% |
Risk & Volatility
HON leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than INV's 2.63 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HON currently trades 87.1% from its 52-week high vs MMM's 81.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.81x | 0.74x | 1.04x | 1.52x |
| 52-Week HighHighest price in past year | $7.45 | $248.18 | $177.41 | $165.15 |
| 52-Week LowLowest price in past year | $2.36 | $186.76 | $137.70 | $108.37 |
| % of 52W HighCurrent price vs 52-week peak | +83.4% | +87.1% | +81.0% | +85.4% |
| RSI (14)Momentum oscillator 0–100 | 66.0 | 45.1 | 48.8 | 61.3 |
| Avg Volume (50D)Average daily shares traded | 1.9M | 3.7M | 3.6M | 2.8M |
Analyst Outlook
Evenly matched — HON and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HON as "Buy", MMM as "Hold", EMR as "Buy". Consensus price targets imply 28.8% upside for INV (target: $8) vs 12.8% for HON (target: $244). For income investors, HON offers the higher dividend yield at 2.14% vs INV's 0.24%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $8.00 | $243.83 | $166.75 | $161.92 |
| # AnalystsCovering analysts | — | 28 | 33 | 41 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | +2.1% | +1.5% | +1.5% |
| Dividend StreakConsecutive years of raises | 1 | 15 | 0 | 37 |
| Dividend / ShareAnnual DPS | $0.01 | $4.63 | $2.18 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.8% | +6.4% | +1.6% |
MMM leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). EMR leads in 1 (Income & Cash Flow). 2 tied.
INV vs HON vs MMM vs EMR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is INV or HON or MMM or EMR a better buy right now?
For growth investors, Innventure, Inc.
(INV) is the stronger pick with 9. 2% revenue growth year-over-year, versus 1. 5% for 3M Company (MMM). 3M Company (MMM) offers the better valuation at 24. 0x trailing P/E (16. 6x forward), making it the more compelling value choice. Analysts rate Honeywell International Inc. (HON) a "Buy" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — INV or HON or MMM or EMR?
On trailing P/E, 3M Company (MMM) is the cheapest at 24.
0x versus Emerson Electric Co. at 34. 9x. On forward P/E, 3M Company is actually cheaper at 16. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Emerson Electric Co. wins at 4. 81x versus Honeywell International Inc. 's 11. 18x.
03Which is the better long-term investment — INV or HON or MMM or EMR?
Over the past 5 years, Emerson Electric Co.
(EMR) delivered a total return of +59. 5%, compared to -37. 9% for Innventure, Inc. (INV). Over 10 years, the gap is even starker: EMR returned +206. 6% versus INV's -30. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — INV or HON or MMM or EMR?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Innventure, Inc. 's 2. 81β — meaning INV is approximately 279% more volatile than HON relative to the S&P 500. On balance sheet safety, Innventure, Inc. (INV) carries a lower debt/equity ratio of 4% versus 3% for 3M Company — giving it more financial flexibility in a downturn.
05Which is growing faster — INV or HON or MMM or EMR?
By revenue growth (latest reported year), Innventure, Inc.
(INV) is pulling ahead at 9. 2% versus 1. 5% for 3M Company (MMM). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -143. 1% for Innventure, Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — INV or HON or MMM or EMR?
3M Company (MMM) is the more profitable company, earning 13.
0% net margin versus -64. 1% for Innventure, Inc. — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus -63. 2% for INV. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is INV or HON or MMM or EMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Emerson Electric Co. (EMR) is the more undervalued stock at a PEG of 4. 81x versus Honeywell International Inc. 's 11. 18x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, 3M Company (MMM) trades at 16. 6x forward P/E versus 21. 7x for Emerson Electric Co. — 5. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INV: 28. 8% to $8. 00.
08Which pays a better dividend — INV or HON or MMM or EMR?
All stocks in this comparison pay dividends.
Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 0. 2% for Innventure, Inc. (INV).
09Is INV or HON or MMM or EMR better for a retirement portfolio?
For long-horizon retirement investors, Honeywell International Inc.
(HON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 2. 1% yield, +132. 4% 10Y return). Innventure, Inc. (INV) carries a higher beta of 2. 81 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HON: +132. 4%, INV: -30. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between INV and HON and MMM and EMR?
These companies operate in different sectors (INV (Financial Services) and HON (Industrials) and MMM (Industrials) and EMR (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
HON, MMM, EMR pay a dividend while INV does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.